Notícias Intesity Therapeutics Inc - INTS | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Intesity Therapeutics Inc (INTS)
Intesity Therapeutics Inc (INTS) Notícias

Intesity Therapeutics Inc (INTS)

2,325

-0,0149

(-0,64%)

No fechamento: 13 Março 5:00PM

Atrasado por 15 minutos

2,22

-0,105

( -4,52% )

Após o horário de negociação: 5:37PM

Atrasado por 15 minutos

Discussões em tempo real e ideias de negociação: Negocie com confiança com nossa poderosa plataforma.

Form 8-K - Current report

Intensity Therapeutics Reports 2024 Year End Financial Results and Provides Corporate Update

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Drug Monitoring Committee Authorizes Continuation of Intensity Therapeutics' Ongoing Global Randomized Phase 3 Sarcoma Trial ("INVINCIBLE-3 Study") Following Periodic Review

Intensity Therapeutics Provides Business Update Highlighting Key Achievements with Lead Drug Candidate INT230-6

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form EFFECT - Notice of Effectiveness

Form S-1 - General form for registration of securities under the Securities Act of 1933

Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Present Phase 2 Data in Presurgical Breast Cancer from the completed INVINCIBLE-2 Study, and an Overview of the Ongoing Randomized, Presurgical Triple Negative Breast Cancer

Form D - Notice of Exempt Offering of Securities

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 8-K - Current report

Intensity Therapeutics, Inc. Announces Pricing of $3 Million Registered Direct Offering and Concurrent Private Placement

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Intesity Therapeutics

Canadian Imperial Bank o...

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições